Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Epigenetic reprogramming of melanoma cells by vitamin C treatment.

Gustafson CB, Yang C, Dickson KM, Shao H, Van Booven D, Harbour JW, Liu ZJ, Wang G.

Clin Epigenetics. 2015 Apr 29;7(1):51. doi: 10.1186/s13148-015-0087-z. eCollection 2015.

2.

Hydroxyapatite versus polyethylene orbital implants for patients undergoing enucleation for uveal melanoma.

Chao DL, Harbour JW.

Can J Ophthalmol. 2015 Apr;50(2):151-4. doi: 10.1016/j.jcjo.2014.11.007.

PMID:
25863856
3.

Gene expression profiling and regression rate of irradiated uveal melanomas.

Rao RC, Khan M, Badiyan SN, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2015 Mar 1;46(3):333-7. doi: 10.3928/23258160-20150323-06.

4.

Serous macular detachment following a systemic corticosteroid injection.

Weng CY, Harbour JW.

JAMA Ophthalmol. 2015 Apr 1;133(4):473-4. doi: 10.1001/jamaophthalmol.2014.5237. No abstract available.

PMID:
25856642
5.

Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.

Herlihy N, Dogrusöz M, van Essen TH, Harbour JW, van der Velden PA, van Eggermond MC, Haasnoot GW, van den Elsen PJ, Jager MJ.

Invest Ophthalmol Vis Sci. 2015 Jan 15;56(3):1447-58. doi: 10.1167/iovs.14-15250.

PMID:
25593028
6.

Rapid regression of a subset of class 1 uveal melanomas after Iodine-125 plaque radiotherapy suggests an inflammatory mechanism.

Chen RW, Harbour JW.

Graefes Arch Clin Exp Ophthalmol. 2014 Dec;252(12):2021-2. doi: 10.1007/s00417-014-2793-1. Epub 2014 Sep 12. No abstract available.

PMID:
25212495
7.

Prognostic parameters in uveal melanoma and their association with BAP1 expression.

van Essen TH, van Pelt SI, Versluis M, Bronkhorst IH, van Duinen SG, Marinkovic M, Kroes WG, Ruivenkamp CA, Shukla S, de Klein A, Kiliç E, Harbour JW, Luyten GP, van der Velden PA, Verdijk RM, Jager MJ.

Br J Ophthalmol. 2014 Dec;98(12):1738-43. doi: 10.1136/bjophthalmol-2014-305047. Epub 2014 Aug 21.

PMID:
25147369
8.

GNAQ/11 mutations in uveal melanoma: is YAP the key to targeted therapy?

Field MG, Harbour JW.

Cancer Cell. 2014 Jun 16;25(6):714-5. doi: 10.1016/j.ccr.2014.05.028.

PMID:
24937456
9.

Distinguishing torpedo maculopathy from similar lesions of the posterior segment.

Villegas VM, Schwartz SG, Flynn HW Jr, Capó H, Berrocal AM, Murray TG, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2014 May-Jun;45(3):222-6. doi: 10.3928/23258160-20140410-01. Epub 2014 Apr 17. Review.

PMID:
24738480
10.

Recent developments in prognostic and predictive testing in uveal melanoma.

Field MG, Harbour JW.

Curr Opin Ophthalmol. 2014 May;25(3):234-9. doi: 10.1097/ICU.0000000000000051. Review.

PMID:
24713608
11.

A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.

Harbour JW, Chao DL.

Ophthalmology. 2014 Jun;121(6):1281-8. doi: 10.1016/j.ophtha.2013.12.014. Epub 2014 Jan 28.

PMID:
24480708
12.

Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.

Badiyan SN, Rao RC, Apicelli AJ, Acharya S, Verma V, Garsa AA, DeWees T, Speirs CK, Garcia-Ramirez J, Esthappan J, Grigsby PW, Harbour JW.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):801-5. doi: 10.1016/j.ijrobp.2013.12.014. Epub 2014 Jan 22.

PMID:
24462385
13.

Combined PKC and MEK inhibition for treating metastatic uveal melanoma.

Sagoo MS, Harbour JW, Stebbing J, Bowcock AM.

Oncogene. 2014 Sep 25;33(39):4722-3. doi: 10.1038/onc.2013.555. Epub 2014 Jan 13.

14.

A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile.

Harbour JW.

Methods Mol Biol. 2014;1102:427-40. doi: 10.1007/978-1-62703-727-3_22.

PMID:
24258991
15.

Retinoblastoma protein prevents enteric nervous system defects and intestinal pseudo-obstruction.

Fu M, Landreville S, Agapova OA, Wiley LA, Shoykhet M, Harbour JW, Heuckeroth RO.

J Clin Invest. 2013 Dec;123(12):5152-64. doi: 10.1172/JCI67653. Epub 2013 Nov 1.

16.

Multimodal imaging of sarcoid choroidal granulomas.

Modi YS, Epstein A, Bhaleeya S, Harbour JW, Albini T.

J Ophthalmic Inflamm Infect. 2013 Aug 23;3(1):58. doi: 10.1186/1869-5760-3-58.

17.

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.

Matatall KA, Agapova OA, Onken MD, Worley LA, Bowcock AM, Harbour JW.

BMC Cancer. 2013 Aug 5;13:371. doi: 10.1186/1471-2407-13-371.

18.

Gene expression profiling versus TNM classification.

Harbour JW, Augsburger JJ, Char DH.

Ophthalmology. 2013 Jul;120(7):e52-3. doi: 10.1016/j.ophtha.2013.03.011. No abstract available.

PMID:
23823531
19.

Author reply: To PMID 22521086.

Harbour JW, Augsburger JJ, Char DH.

Ophthalmology. 2013 Jul;120(7):e51. doi: 10.1016/j.ophtha.2013.03.037. No abstract available.

PMID:
23823529
20.

Genomic, prognostic, and cell-signaling advances in uveal melanoma.

Harbour JW.

Am Soc Clin Oncol Educ Book. 2013:388-91. doi: 10.1200/EdBook_AM.2013.33.388.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk